I don't know how to treat amyloidosis

Research output: Contribution to journalComment/debate

23 Scopus citations

Abstract

In this issue of Blood, Dietrich and colleagues report disappointing results with the use of melphalan parenterally with dexamethasone in patients with immunoglobulin light chain amyloidosis. The median survival of 61 patients was 17.5 months. The 3 months all cause mortality was 28%.

Original languageEnglish (US)
Pages (from-to)507-508
Number of pages2
JournalBlood
Volume116
Issue number4
DOIs
StatePublished - Jul 29 2010

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Fingerprint Dive into the research topics of 'I don't know how to treat amyloidosis'. Together they form a unique fingerprint.

  • Cite this